Cardiovascular Research, 2023 Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease Davidsson P., Eketjäll S., Eriksson N. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |
Ocular Immunology and Inflammation, 2023 Non-Infectious Uveitis Secondary to Dupilumab Treatment in Atopic Dermatitis Patients Shows a Pro-Inflammatory Molecular Profile Achten R., van Luijk C., Thijs J. et al. Olink Target 96OphthalmologyDermatological DiseasesPathophysiologyAqueous Humor | | | | |
eBioMedicine, 2023 Association between proteomic biomarkers and myocardial fibrosis measured by MRI: the multi-ethnic study of atherosclerosis Bakhshi H., Michelhaugh S., Bruce S. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |
Biomedicines, 2023 Inflammatory Blood Signature Related to Common Psychological Comorbidity in Chronic Pain Karshikoff B., Wåhlén K., Åström J. et al. Olink Target 96NeurologyPatient StratificationPlasma | | | | |
PROTEOMICS – Clinical Applications, 2023 Analytical validation of a multi‐protein, serum‐based assay for disease activity assessments in multiple sclerosis Qureshi F., Hu W., Loh L. et al. Olink FocusNeurologyPatient StratificationTechnical EvaluationSerum | | | | |
Molecular Medicine, 2023 Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning Patel M., Knauer M., Nicholson M. et al. Olink Explore 3072/384Infectious DiseasesPatient StratificationPlasma | | | | |
Respiratory Research, 2023 Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia Palma Medina L., Babačić H., Dzidic M. et al. Olink Target 96Infectious DiseasesPatient StratificationPlasma | | | | |
Nature Metabolism, 2023 Proteogenomic links to human metabolic diseases Koprulu M., Carrasco-Zanini J., Wheeler E. et al. Olink Explore 3072/384Metabolic DiseasesPathophysiologySerum | | | | |
Nature Communications, 2023 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial Othonos N., Pofi R., Arvaniti A. et al. Olink Target 48Immunological & Inflammatory DiseasesPathophysiologySerum | | | | |
JCI Insight, 2023 Vitamin D3 and deconvoluting a rash Ernst M., Evans S., Techner J. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma | | | | |
Journal of Allergy and Clinical Immunology, 2023 Proteomic and transcriptomic screening demonstrates increased mast cell–derived CCL23 in systemic mastocytosis Söderlund S., Boey D., van Midden W. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma | | | | |
Inflammation Research, 2023 Screening inflammatory protein biomarkers on premature infants with necrotizing enterocolitis Dong H., Zhang L., Li B. et al. Olink Target 96Other Diseases & SyndromesPatient StratificationPlasma | | | | |
The Journal of Clinical Endocrinology & Metabolism, 2023 Disease Duration and Chronic Complications Associate With Immune Activation in Individuals With Longstanding Type 1 Diabetes Ajie M., van Heck J., Janssen A. et al. Olink Target 96Metabolic DiseasesPathophysiologyPlasma | | | | |
BJU International, 2023 Urine supernatant reveals a signature that predicts survival in clear‐cell renal cell carcinoma Daza J., Salomé B., Okhawere K. et al. Olink Target 96OncologyPatient StratificationPlasmaUrine | | | | |
Frontiers in Genetics, 2023 Circulatory proteins relate cardiovascular disease to cognitive performance: A mendelian randomisation study Huang J., Gill D., Zuber V. et al. Olink Target 96CVDNeurologyPathophysiologyPlasma | | | | |
Leukemia, 2023 Cognitive impairments correlate with increased central nervous system immune activation after allogeneic haematopoietic stem cell transplantation Boberg E., Kadri N., Hagey D. et al. Olink Target 96NeurologyPathophysiologyCSF | | | | |
International Journal of Molecular Sciences, 2023 Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma Sandström K., Ehrsson Y., Sellberg F. et al. Olink Target 96OncologyPatient StratificationSerum | | | | |
Gut, 2023 Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis Leibovitzh H., Lee S., Raygoza Garay J. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum | | | | |
Journal of Nanobiotechnology, 2023 Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment Cano A., Esteban-de-Antonio E., Bernuz M. et al. Olink Target 96NeurologyPatient StratificationPlasmaEV LysateCSF | | | | |
Obesity Medicine, 2023 Biomarker screening in children and adolescents reveals that CUB domain-containing protein 1 is associated with obesity and that hepatocyte growth factor is associated with weight gain Manell H., Shen Q., Chowdhury A. et al. Olink Target 96Metabolic DiseasesPathophysiologyPlasma | | | | |